Co-infection models of Staphylococcus aureus and respiratory viruses reveal synergistic interactions counteracted by a bithiazole derivative
The bithiazole compound, MR335, effectively counteracted the synergistic interactions between respiratory viruses and S. aureus at concentration that retained antiviral but not antibacterial activity, suggesting their synergistic cooperation and opening the way to alternative therapies that prevent bacterial superinfec...